News Briefs

04/18/2022

FDA gives Lupin approval, tentative OK for 2 generics

Image
Pill bottles with white pills

The Food and Drug Administration has given Lupin permission for desvenlafaxine extended-release tablets, in a dosage strength of 25 mg.

The product, a generic of Pfizer's Pristiq is used for the treatment of major depressive disorder in adults, and will be manufactured at Lupin’s facility in Goa, India.

Desvenlafaxine ER tablets have a market value of roughly $14 million, according to IQVIA December 2021 data.

The FDA also gave Lupin a tentative nod for tenofovir alafenamide tablets, 25 mg.

The medication, a generic of Gilead’s Vemlidy, is used to treat chronic (long-lasting) hepatitis B virus in adults with stable (compensated) liver disease, and will be manufactured at Lupin’s Nagpur facility in India.

Alafenamide tablets have a market value of roughly $484.2 million, according to December 2021 IQVIA data.

Advertisement
04/18/2022

Pop-Tarts brings back ’90s-inspired frosted grape flavor

Image
Frosted Grape Pop-Tarts

Pop-Tarts is giving into 90s nostalgia by bringing back a classic flavor from the past.

The Battle Creek, Mich.-based company announced that its frosted grape flavor is making a comeback this spring.

“At Pop-Tarts, we know what our fans want. Frosted Grape has been among the top flavors fans have been asking us to bring back,” said Heidi Ray, senior director of marketing, portable wholesome snacks. “So, we could not be more stoked to finally bring back this Pop-Tarts G.O.A.T. – Grape-ist Of All Time.”

Featuring the classic grape jelly filling, white icing and purple crunch-lets, the frosted grape Pop-Tarts will be available at retailers nationwide beginning in May in an eight-count box that retails for $3.19.

04/15/2022

Martha Stewart CBD releases new Tropical Medley CBD Wellness Gummies

Image
martha stewart cbd wellness gummies

Martha Stewart CBD has expanded its portfolio of Tropical Medley CBD Wellness Gummies. According to the brand, the new product offering features three flavors inspired by the lush fruits of tropical destinations: Alphonso mango, coconut and pineapple.

The latest flavors, previewed by Martha Stewart at a Palm Beach, Fla. event in February, will transport consumers to sunny destinations, offering a new addition to the brand’s lineup of convenient and trusted flexible wellness solutions, the company said.

“My favorite tropical fruits, Alphonso mango, coconut and pineapple, were the inspiration for this new offering,” Stewart said. “Now, our loyal customers can take a moment to prioritize their well-being and relax their mind through the lush flavors of the tropics. It’s always a pleasure to create new products that make wellness more accessible, convenient and delicious.”

Each gourmet gummy features texture and 100% hemp-derived CBD isolate, and the gummies are part of Stewart’s continued partnership with Canopy Growth, a diversified cannabis and cannabinoid-based consumer product company.

Martha Stewart CBD Tropical Medley Wellness Gummies are available in the following at marthastewartcbd.com:

  • 30-count offering ($34.99);
  • 10-count offering ($12.99) in April; and
  • 3-count offering ($3.99) in April.

“The new Tropical Medley CBD Wellness Gummies feature three delicious flavors and are made with Canopy Growth’s high-quality, U.S.-grown CBD isolate, which is the purest and most potent form of CBD, offering consumers the consistent and great-tasting experience they’ve come to love from Martha Stewart CBD,” said Tara Rozalowsky, interim chief product officer at Canopy Growth. “As we gear up for spring break season, we can’t wait for consumers to kick off getting into a tropical mindset with these new flavors inspired by their favorite sunny destinations.”

Advertisement
04/14/2022

Sandoz debuts generic Combigan

Image

Sandoz is introducing a generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution, 0.2%/0.5%.

The medication, the generic of AbbVie's Allergan unit's Combigan, is used to lower eye pressure in patients with ocular hypertension or high eye pressure, and is now available to patients via retail pharmacies, according to the company. 

Anyone can develop ocular hypertension, but certain groups are at higher risk, including but not limited to African Americans and Hispanics, people over 40 years old, people living with diabetes or high blood pressure, people who are very myopic (near-sighted), and people who take long-term steroid medicines. It is important to treat high eye pressure before it causes damage to the optic nerve and vision loss, the company said.

“Fixed combinations of medicines to treat ocular hypertension can offer patients enhanced convenience, improved adherence, reduced exposure to preservatives and cost savings,” said Keren Haruvi, president of Sandoz. “We developed this important generic eye treatment in-house to expand patient access to high-quality, more affordable eye care for millions of U.S. patients.”

04/13/2022

Alembic rolls out generic Emla cream

Image
lidocane teaser

Alembic is introducing lidocaine and prilocaine cream 2.5%/2.5%. 

Alembic’s product is the generic of Teva’s Emla cream.

It is indicated as a topical anesthetic for use on normal intact skin for local analgesia.

Alembic's lidocaine and prilocaine cream 2.5%/2.5% is available in a 30-gm tube.

04/13/2022

Lupin offers generic Taytulla

Image
Pill bottles with white pills

Lupin is offering Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg under an exclusive license, marketing and distribution agreement with Slayback.

Merzee is the generic of Allergan’s Taytulla.

It is a low-dose prescription birth control pill with 20 micrograms of daily estrogen.

Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had a market value of roughly $90 million, according to IQVIA February 2022 data.